Application of Serum Bile Acid Profile in the Diagnosis of Gastric Cancer

Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC

NCT04638959 ·Status: UNKNOWN

Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

NCT06335576 ·Status: NOT_YET_RECRUITING

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

NCT03957564 ·Status: UNKNOWN ·Phase: PHASE2

Predicting Biomarker of Gastric Cancer Chemotherapy Response

NCT03253107 ·Status: RECRUITING

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer

NCT06079554 ·Status: RECRUITING

Transcriptomic Signatures in Gastric Adenocarcinoma

NCT05319392 ·Status: UNKNOWN

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

NCT01756183 ·Status: UNKNOWN ·Phase: PHASE2

The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling

NCT04501887 ·Status: UNKNOWN

Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer

NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

NCT01053390 ·Status: COMPLETED ·Phase: PHASE3

Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer

NCT06478394 ·Status: RECRUITING

Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer

NCT07003334 ·Status: RECRUITING

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

NCT04487717 ·Status: ACTIVE_NOT_RECRUITING

Nutrition-support-team Based Intervention in Patients With Advanced Gastrointestinal Cancer

NCT03631537 ·Status: UNKNOWN ·Phase: NA

The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study

NCT02583659 ·Status: UNKNOWN

General Tissue Response Classification System After Chemotherapy

NCT03791268 ·Status: UNKNOWN

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

NCT06100003 ·Status: RECRUITING

Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy

NCT06277453 ·Status: ACTIVE_NOT_RECRUITING

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer

NCT02289378 ·Status: UNKNOWN ·Phase: PHASE2

Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers

NCT01650766 ·Status: UNKNOWN

the Optimal Surveillance Frequency for Stage II/III Gastric Cancer

NCT05465993 ·Status: COMPLETED

Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy

NCT01905969 ·Status: UNKNOWN

Early Diagnosis of Gastric Cancer Cachexia

NCT06277986 ·Status: RECRUITING

The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer

NCT02431078 ·Status: UNKNOWN

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

NCT04047953 ·Status: RECRUITING ·Phase: NA